| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
6.5 Analysis of a Large Payer Claims Database Suggests Elderly Patients with Diabetes are Under-Treated (1257-P)
|
Slabaugh, S. Lane
|
|
2013
|
11 |
3 |
p. 97
|
artikel
|
| 2 |
3. Behandelstrategieën via het incretinesysteem – hoe veilig is dat eigenlijk?
|
|
|
2013
|
11 |
3 |
p. 86-87
|
artikel
|
| 3 |
2.3 Cardiovascular (CV) Safety of Linagliptin in Patients with Type 2 Diabetes (T2D): A Pooled Comprehensive Analysis of Prospectively Adjudicated CV Events in Phase 3 Studies (376-OR)
|
Johansen, Odd Erik
|
|
2013
|
11 |
3 |
p. 83-84
|
artikel
|
| 4 |
2.1 Change in Body Weight After 24 Weeks of Vildagliptin Therapy as a Function of Baseline Glucose Levels in Patients with Type 2 Diabetes (372-OR)
|
Foley, James E.
|
|
2013
|
11 |
3 |
p. 81-82
|
artikel
|
| 5 |
8. De diabetes control and complications trial (DCCT) en de vervolgstudie daarvan: de epidemiology of diabetes interventions and complications (EDIC).
|
|
|
2013
|
11 |
3 |
p. 101-102
|
artikel
|
| 6 |
De implementatie van de NDF Zorgstandaard Diabetes anno 2013
|
Raaijmakers, L.G.M. (Lieke)
|
|
2013
|
11 |
3 |
p. 104-109
|
artikel
|
| 7 |
6. De oudere patiënt met diabetes
|
|
|
2013
|
11 |
3 |
p. 93
|
artikel
|
| 8 |
5. Diabetes en zwangerschap
|
|
|
2013
|
11 |
3 |
p. 92
|
artikel
|
| 9 |
2. Dpp-4-remmers in de praktijk – meerdere behandelstrategieën vergeleken
|
|
|
2013
|
11 |
3 |
p. 81
|
artikel
|
| 10 |
5.2. Effectiveness of Continuous Glucose Monitoring and Fingerstick Blood Glucose Monitoring in Pregnancy Outcome of Gestational Diabetes (2692-PO)
|
Ding, Gui Feng
|
|
2013
|
11 |
3 |
p. 93
|
artikel
|
| 11 |
1.2 Efficacy and Safety of Dulaglutide versus Placebo and Exenatide in Type 2 Diabetes (AWARD-1) (66-OR)
|
Wysham, Carol H.
|
|
2013
|
11 |
3 |
p. 75-76
|
artikel
|
| 12 |
1.5 Efficacy and Safety of Dulaglutide vs. Metformin in Type 2 Diabetes (AWARD-3) (69-OR)
|
Umpierrez, Guillermo E.
|
|
2013
|
11 |
3 |
p. 78
|
artikel
|
| 13 |
1.7 Efficacy and Safety of Dulaglutide vs. Sitagliptin after 52 Weeks in Type 2 diabetes (AWARD-5) (71-OR)
|
Nauck, Michael A.
|
|
2013
|
11 |
3 |
p. 79-80
|
artikel
|
| 14 |
6.3 Efficacy and Safety of Lixisenatide in Elderly T2DM Patients: Subanalysis from the GetGoal Program (916-P)
|
Hanefeld, Markolf
|
|
2013
|
11 |
3 |
p. 95-96
|
artikel
|
| 15 |
1.6 Exenatide BID vs. Insulin Lispro TIDM Added to Titrated Insulin Glargine QD in Metformin-Treated T2DM Patients Resulted in Similar Glycemic Control but Weight Loss and Less Hypoglycemia: The 4B Study (70-OR)
|
Diamant, Michaela
|
|
2013
|
11 |
3 |
p. 79
|
artikel
|
| 16 |
1.3 Exenatide Once Weekly: Sustained Glycemic and Weight Control Through 3 Years Compared with Insulin Glargine (67-OR)
|
Trautmann, Michael
|
|
2013
|
11 |
3 |
p. 76
|
artikel
|
| 17 |
1. Glp-1-agonisten in de praktijk – meerdere behandelstrategieën vergeleken
|
|
|
2013
|
11 |
3 |
p. 74
|
artikel
|
| 18 |
1.4 Harmony 8: Once Weekly (QW) GLP1 Agonist Albiglutide (Albi) vs. Sitagliptin (Sita) in Type 2 Diabetes (T2D) Pts With Renal Impairment (RI): Week 26 Results (68-OR)
|
Leiter, Lawrence A.
|
|
2013
|
11 |
3 |
p. 76-77
|
artikel
|
| 19 |
1.1 IDegLira, a Novel Fixed Ratio Combination of Insulin Degludec and Liraglutide, is Efficacious and Safe in Subjects with Type 2 Diabetes: A Large, Randomized Phase 3 Trial (65-OR)
|
Buse, John B.
|
|
2013
|
11 |
3 |
p. 74-75
|
artikel
|
| 20 |
7.4 Improved Glycemic Control Despite Reductions in Bolus Insulin Doses with Basal Insulin LY2605541 Compared with Basal Insulin Glargine in Patients with Type 1 Diabetes (915-P)
|
Rosenstock, Julio
|
|
2013
|
11 |
3 |
p. 100
|
artikel
|
| 21 |
1.8 Initial Triple Combination Therapy is Superior to Stepwise Add-On Conventional Therapy in Newly Diagnosed T2DM (72-OR)
|
Abdul-Ghani, Muhammad A.
|
|
2013
|
11 |
3 |
p. 80-81
|
artikel
|
| 22 |
Kenneth Barlow: de eerste gedocumenteerde zaak van moord met insuline
|
Marks, V. (Vincent)
|
|
2013
|
11 |
3 |
p. 110-112
|
artikel
|
| 23 |
7.3. Lower Within-Subject Variability in Mean Blood Glucose Concentration with Insulin Degludec vs. Insulin Glargine: A Meta-Analysis of Patients with T2D (914-P)
|
Meneghini, Luigi F.
|
|
2013
|
11 |
3 |
p. 99-100
|
artikel
|
| 24 |
4. Metformine – nieuwsfeiten over een oud geneesmiddel
|
|
|
2013
|
11 |
3 |
p. 88-89
|
artikel
|
| 25 |
4.2 Metformine: nieuwsfeiten voor de praktijk
|
|
|
2013
|
11 |
3 |
p. 90-92
|
artikel
|
| 26 |
Moleculair werkingsmechanisme van metformine: oude of nieuwe inzichten?
|
Rena, G. (Graham)
|
|
2013
|
11 |
3 |
p. 113-122
|
artikel
|
| 27 |
7. Nieuwe insulinepreparaten en toedieningsvormen – wat is de meerwaarde?
|
|
|
2013
|
11 |
3 |
p. 98
|
artikel
|
| 28 |
6.4 Now or Later? Real-World Study of Impact of Timing of Insulin Initiation on Outcomes Among Elderly Medicare Patients With Type 2 Diabetes Mellitus (1213-P)
|
Sambamoorthi, Usha
|
|
2013
|
11 |
3 |
p. 96-97
|
artikel
|
| 29 |
7.2 Physical Health Status and Nocturnal Hypoglycemia with Insulin Degludec vs. Insulin Glargine: A 2-Year Trial in Insulin-Naïve Patients with Type 2 Diabetes (934-P)
|
Rodbard, Helena W.
|
|
2013
|
11 |
3 |
p. 98-99
|
artikel
|
| 30 |
6.2 Prevalence and Factors Associated With Hospital Re-Admissions Among Elderly Medicare Beneficiaries With Type 2 Diabetes Mellitus (262-OR)
|
Raval, Amit
|
|
2013
|
11 |
3 |
p. 94
|
artikel
|
| 31 |
Quid Novum?
|
Beek, André van
|
|
2013
|
11 |
3 |
p. 72
|
artikel
|
| 32 |
7.5 Reduction of Severe Hypoglycemia with Sensor-Augmented Insulin Pump Therapy and Automated Insulin Suspension in Patients with Type 1 Diabetes (228-OR)
|
Ly, Trang T.
|
|
2013
|
11 |
3 |
p. 101
|
artikel
|
| 33 |
Review wetenschappelijk congres American Diabetes Association
|
Kooy, A. (Adriaan)
|
|
2013
|
11 |
3 |
p. 73
|
artikel
|
| 34 |
9. Samenvatting en slotsom
|
|
|
2013
|
11 |
3 |
p. 102-103
|
artikel
|
| 35 |
2.4 Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Improves the Unfavorable M1/M2- Like Phenotypes of Peripheral Blood Monocytes in Japanese Type 2 Diabetic Patients (377-OR)
|
Satoh-Asahara, Noriko
|
|
2013
|
11 |
3 |
p. 84
|
artikel
|
| 36 |
2.2 Study of Efficacy and Safety of Sitagliptin in Patients of Type 2 Diabetes when Added to Insulin Therapy Alone or With Metformin (373-OR)
|
Singh, Devendra P.
|
|
2013
|
11 |
3 |
p. 82-83
|
artikel
|
| 37 |
2.6 The Changes of Leukocyte Telomere Length and Telomerase Activity after Intervention of Sitagliptin in Initial Type 2 Diabetes (1173-P)
|
Ma, Delin
|
|
2013
|
11 |
3 |
p. 85-86
|
artikel
|
| 38 |
2.5 The Effect of DPP-4 Inhibitor, Alogliptin, on Bone Metabolism in Patients with Type 2 Diabetes Mellitus (1071-P)
|
Yamauchi, Yuichiro
|
|
2013
|
11 |
3 |
p. 85
|
artikel
|
| 39 |
5.1 Women with Gestational Diabetes Randomized to a Low-Carbohydrate/Higher Fat Diet Demonstrate Greater Insulin Resistance and Infant Adiposity (73-OR)
|
Hernandez, Teri L.
|
|
2013
|
11 |
3 |
p. 92
|
artikel
|
Tijdschrift beschrijving